The 5-lipoxygenase inhibitors ZD2138 and ZM230487 are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses
- 1 May 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 257 (3) , 285-292
- https://doi.org/10.1016/0014-2999(94)90140-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitorsJournal of Medicinal Chemistry, 1992
- The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitorInternational Journal of Immunopharmacology, 1992
- The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjectsJournal of Allergy and Clinical Immunology, 1988
- Leukotrienes and Airway ResponsesAmerican Review of Respiratory Disease, 1987
- Radioinmunoassay of LTB4 and 6-trans LTB4: Analytical and pharmacological characterisation of immunoreactive LTB4 in ionophore stimulated human bloodProstaglandins, Leukotrienes and Medicine, 1986
- Actions of inhaled leukotrienes and their interactions with other allergic mediatorsProstaglandins, 1984
- The Role of Arachidonic Acid Oxygenation Products in Pain and InflammationAnnual Review of Immunology, 1984
- Determination of SRS-A release from guinea-pig lungs by a radioimmunoassayBiochemical and Biophysical Research Communications, 1983
- THE PHARMACOLOGY AND PATHOPHYSIOLOGY OF LEUKOTRIENE B4British Medical Bulletin, 1983
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980